Search research articles
Contact Us
Filters
Showing results (61-70 of 92) with videos related to
Page
of 10
Sort By:
Clinical and Experimental Rheumatology
|
September 22, 2022
Reactogenicity, safety and disease flares following BNT162b2 mRNA COVID-19 vaccine in patients with chronic immune-inflammatory arthritis treated with biological and targeted synthetic disease-modifying anti-rheumatic drugs
Ludovico De Stefano, Silvia Balduzzi, Laura Bogliolo, et al.
Autoimmunity Reviews
|
July 15, 2022
Seronegative autoimmune diseases: A challenging diagnosis
Marco Vincenzo Lenti, Carlo Maria Rossi, Federica Melazzini, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 7, 2018
A Multicenter Retrospective Analysis Evaluating Performance of Synovial Biopsy Techniques in Patients With Inflammatory Arthritis: Arthroscopic Versus Ultrasound-Guided Versus Blind Needle Biopsy
Frances Humby, Vasco C Romão, Antonio Manzo, et al.
Pragmatic and Observational Research
|
May 8, 2023
Administrative Databases and Diagnostic Therapeutic and Assistance Paths -PDTA- in the Monitoring Treatment of Rheumatoid Arthritis: The Experience of ATS Pavia
Giacomo M Bruno, Maria Chiara Valentino, Alessandra Brunetti, et al.
Frontiers in Nutrition
|
July 22, 2022
Vitamin D 25OH Deficiency and Mortality in Moderate to Severe COVID-19: A Multi-Center Prospective Observational Study
Laura Bogliolo, Emanuele Cereda, Catherine Klersy, et al.
Clinical and Experimental Rheumatology
|
April 18, 2024
Effectiveness and safety of filgotinib in rheumatoid arthritis patients: data from the GISEA registry
Marco Fornaro, Roberto Caporali, Martina Biggioggero, et al.
Clinical Rheumatology
|
April 21, 2021
Retention rate of a second line with a biologic DMARD after failure of a first-line therapy with abatacept, tocilizumab, or rituximab: results from the Italian GISEA registry
Marco Sebastiani, Vincenzo Venerito, Serena Bugatti, et al.
Clinical and Experimental Rheumatology
|
September 13, 2011
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy
Roberto Caporali, Fabrizio Conti, Stefano Alivernini, et al.
European Journal of Internal Medicine
|
October 18, 2021
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group
Fabio Cacciapaglia, Francesca Romana Spinelli, Matteo Piga, et al.
Rheumatology (Oxford, England)
|
April 19, 2022
Cytokine profile, ferritin and multi-visceral involvement characterize macrophage activation syndrome during adult-onset Still's disease
Piero Ruscitti, Francesco Ursini, Onorina Berardicurti, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 92) with videos related to
Sort By:
Page
of 10
Clinical and Experimental Rheumatology
|
September 22, 2022
Reactogenicity, safety and disease flares following BNT162b2 mRNA COVID-19 vaccine in patients with chronic immune-inflammatory arthritis treated with biological and targeted synthetic disease-modifying anti-rheumatic drugs
Ludovico De Stefano, Silvia Balduzzi, Laura Bogliolo, et al.
Autoimmunity Reviews
|
July 15, 2022
Seronegative autoimmune diseases: A challenging diagnosis
Marco Vincenzo Lenti, Carlo Maria Rossi, Federica Melazzini, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 7, 2018
A Multicenter Retrospective Analysis Evaluating Performance of Synovial Biopsy Techniques in Patients With Inflammatory Arthritis: Arthroscopic Versus Ultrasound-Guided Versus Blind Needle Biopsy
Frances Humby, Vasco C Romão, Antonio Manzo, et al.
Pragmatic and Observational Research
|
May 8, 2023
Administrative Databases and Diagnostic Therapeutic and Assistance Paths -PDTA- in the Monitoring Treatment of Rheumatoid Arthritis: The Experience of ATS Pavia
Giacomo M Bruno, Maria Chiara Valentino, Alessandra Brunetti, et al.
Frontiers in Nutrition
|
July 22, 2022
Vitamin D 25OH Deficiency and Mortality in Moderate to Severe COVID-19: A Multi-Center Prospective Observational Study
Laura Bogliolo, Emanuele Cereda, Catherine Klersy, et al.
Clinical and Experimental Rheumatology
|
April 18, 2024
Effectiveness and safety of filgotinib in rheumatoid arthritis patients: data from the GISEA registry
Marco Fornaro, Roberto Caporali, Martina Biggioggero, et al.
Clinical Rheumatology
|
April 21, 2021
Retention rate of a second line with a biologic DMARD after failure of a first-line therapy with abatacept, tocilizumab, or rituximab: results from the Italian GISEA registry
Marco Sebastiani, Vincenzo Venerito, Serena Bugatti, et al.
Clinical and Experimental Rheumatology
|
September 13, 2011
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy
Roberto Caporali, Fabrizio Conti, Stefano Alivernini, et al.
European Journal of Internal Medicine
|
October 18, 2021
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group
Fabio Cacciapaglia, Francesca Romana Spinelli, Matteo Piga, et al.
Rheumatology (Oxford, England)
|
April 19, 2022
Cytokine profile, ferritin and multi-visceral involvement characterize macrophage activation syndrome during adult-onset Still's disease
Piero Ruscitti, Francesco Ursini, Onorina Berardicurti, et al.
Page
of 10